Journal: Liver Research
Article Title: Aluminum adjuvant promotes liver inflammation and fibrosis in mice: A novel approach to establish a liver fibrosis animal model
doi: 10.1016/j.livres.2025.05.001
Figure Lengend Snippet: Imject Alum increased the level of pro-inflammatory factors and inflammatory cells in the liver. (A) qRT-PCR analysis of specific leukocyte markers in the liver of Imject Alum (Al(OH) 3 160 mg/kg) D54 and control (CTR) groups. CTR group, n = 8; Imject Alum (Al(OH) 3 160 mg/kg) D54 group, n = 10. ∗ P < 0.05, compared with the CTR group. ns, no significant. (B) Representative immunohistochemical staining with F4/80 for macrophages in the liver from different groups. (C) Representative immunohistochemical staining with Cd3e for T lymphocytes in the liver from different groups. (D) Representative immunofluorescence staining of hepatic Cd11b. (E) Quantitative analysis of hepatic F4/80 and Cd3e immunohistochemical staining. CTR group, n = 8; Imject Alum (Al(OH) 3 160 mg/kg) D54 group, n = 10. ∗ P < 0.05, compared with the CTR group. (F) Hepatic mRNA expression of cytokines, chemokines, and cell adhesion molecules (CAMs) significantly increased in Imject Alum (Al(OH) 3 160 mg/kg) D54 group. CTR group, n = 8; Imject Alum (Al(OH) 3 160 mg/kg) D54 group, n = 10. ∗ P < 0.05, compared with the CTR group. (G) Relative levels of pyroptosis protein markers in the CTR and Imject Alum (Al(OH) 3 160 mg/kg) D54 groups. (H) Primary mouse hepatocyte mRNA levels of pyroptosis markers were significantly increased after treating with Imject Alum. n = 3. ∗ P < 0.05, compared with PBS group. # P < 0.05, compared with Imject Alum (Al(OH) 3 0.5 mg/mL) group. (I) The NLRP3 inhibitor MCC950 can inhibit the activation of primary mouse hepatocyte pyroptosis induced by Imject Alum. n = 3. ∗ P < 0.05, compared with PBS group. # P < 0.05, compared with Imject Alum (Al(OH) 3 1 mg/mL) group. Abbreviations: Asc, apoptosis-associated speck-like protein containing a caspase recruitment domain; Ccl2, C–C motif ligand 2; Cxcl, CXC motif chemokine ligand; Gsdmd, gasdermin D; Icam1, intercellular adhesion molecule 1; Il, interleukin; MOD, mean optical density; Nlrp3, nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin domain-containing 3; PBS, phosphate-buffered saline; qRT-PCR, quantitative real-time polymerase chain reaction; Tnf-α, tumor necrosis factor-alpha; Vcam1, vascular cell adhesion molecule 1.
Article Snippet: Primary mouse hepatocytes were isolated from 8 to 10-week-old wild-type C57BL/6J mice, following a previously described protocol, then plated into collagen-coated 6-well plates (Corning, New York, USA), cultured in William's E Medium (Gibco, Thermo scientific, Rockford, IL, USA), supplemented with 5% fetal bovine serum (FBS; Lonsera, Suzhou, China), and subsequently treated with 0 μg/mL, 500 μg/mL, or 1 mg/mL of Imject Alum (Thermo Scientific), with or without prior administration of the nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin domain-containing 3 (NLRP3) inhibitor MCC950 (1 μmol/L; MedChemExpress, Monmouth Junction, NJ, USA) for 1 h. Total RNA was extracted after 12 h of Imject Alum (Thermo Scientific) treatment and subsequently used for quantitative real-time polymerase chain reaction (qRT-PCR) analysis.
Techniques: Quantitative RT-PCR, Control, Immunohistochemical staining, Staining, Immunofluorescence, Expressing, Activation Assay, Binding Assay, Saline, Real-time Polymerase Chain Reaction